ICR Healthcare’s 14th Annual Healthcare Conference
Monday 16th November 2026
12pm lunch followed by panel discussions and networking drinks from 5pm
De Vere Grand Connaught Rooms
61-65 Great Queen St, London WC2B 5DA
Confirmed speakers so far include
Dima Kuzmin
Managing Partner
4BIO Capital
Jack O’Meara
Co-Founder and CEO
Aerska
Shaun Grady
Chair, UK
AstraZeneca
Christian Angermayer
Founder and Investor, Former Chair
Atai Beckley
Rodolphe Clerval
CEO
Coave Therapeutics
Hannah Kuchler
Global Pharmaceutical Editor
Financial Times
Mike Mortimer
Managing Partner and Founder
GHO Capital
Daniyal Hussain
Executive Director, Technology Business Development
GSK
Hoyin Lam
Director Business Development Search and Evaluation Oncology
GSK
Tim Guilliams
Co-Founder and CEO
Healx
Mads Behrndt
CFO & General Manager
Hemab Therapeutics
Eileen Jennings-Brown
CTO
Juvenescence
Erik van den Berg
CEO
Memorises Bio
Jon Rees
Co-Founder and CEO
MitoRx Therapeutics
Dave Powell
President of Drug Discovery
Relation Therapeutics
Laurene Danon
Advisor to the CEO
Sensorion
Roel Bulthuis
Executive Partner
Syncona
Ken Macnamara
CEO
Trogenix
Agenda
| Time | Session |
| 12:00–13:00 | Lunch and Networking |
| 13:00–13:05 | Introduction: Amber Fennell, Senior Partner, ICR Healthcare |
| 13:05–13:50 | Panel 1: Asian innovation, global growth: how China and Asia are impacting the healthcare ecosystem |
| 13:50–14:35 | Panel 2: From early science to exit: navigating a path to IPO or strategic sale |
| 14:35–15:20 | Break |
| 15:20–16:05 | Panel 3: How AI is remaking drug discovery and development and changing the face of healthcare |
| 16:05–16:50 | Fireside Chat: Christian Angermayer, serial biopharma founder and technology investor, talks disruption and development with Hannah Kuchler, Global Pharmaceutical Editor, Financial Times |
| 16:50–17:00 | Closing remarks: Mary-Jane Elliott, Managing Partner, ICR Healthcare |
| 17:00–18:30 | Networking drinks |
